Clinical Trials Logo
  1. Home
  2. Fatty Liver, Nonalcoholic
  3. NCT03260543

Efficacy and Safety of Fermented Ginseng Powder on Liver Function

Fatty Liver, Nonalcoholic Clinical Trial

Official title:
A 12-week, Randomized, Double-blind, Placebo-controlled Human Trial to Evaluate the Efficacy and Safety of Fermented Ginseng Powder on Liver Function

Clinical Trial Summary

This study was conducted to investigate the effects of daily supplementation of fermented ginseng powder on improvement of Liver function.

Clinical Trial Description

The investigators performed a 12-week, randomized, double-blind, placebo-controlled human trial to evaluate the efficacy and safety of fermented ginseng powder on improvement of Liver function. The investigators measured ALT(Alanine Transaminase) profiles, Liver function index, fatty liver grade, lipid metabolism index, total antioxidant capacity, imflammation index, and Multidimensional Fatigue Scale. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT03260543
Study type Interventional
Source Chonbuk National University Hospital
Contact
Status Completed
Phase N/A
Start date July 2016
Completion date August 2017
View Details
See also
  Status Clinical Trial Phase
Completed NCT03319199 - The Effect of Combination Therapy Amino Acid L-CARNITINE and Magnesium on Fatty Liver N/A
Recruiting NCT05220956 - Impact of Time-restricted Feeding in NAFLD N/A
Active, not recruiting NCT04067440 - Characterization of the Microbiome in Peritoneum, Jejunum, Rectum and Stool
Completed NCT04509245 - The Effects of a Novel Lifestyle Intervention Program on Insulin Sensitivity in Type 2 Diabetes N/A
Completed NCT03656744 - A Study of HTD1801 in Adults With Nonalcoholic Steatohepatitis (NASH) and Type 2 Diabetes Mellitus (T2DM) Phase 2
Not yet recruiting NCT06117137 - The Impact Of SGLT2 -I on Metabolic Dysfunction -Associated Steatotic Liver Disease In Patients With Type 2 Diabetes Mellitus Phase 3
Completed NCT02132780 - Autonomic Dysfunction in Non-Alcoholic Fatty Liver Disease N/A
Active, not recruiting NCT04241575 - Identification of Fatty Liver With Advanced Fibrosis in Type 2 Diabetes Using Simple Fibrosis Scores and Electronic Reminder Messages N/A
Completed NCT02290106 - Effects of Pitavastatin on Insulin Sensitivity and Liver Fat N/A
Completed NCT03784716 - Ketogenic Diet in Non-alcoholic Fatty Liver Disease N/A
Recruiting NCT05558592 - Evaluation of the Effects of Orange Consumption on Carbohydrate and Lipid Metabolism in Subjects With MAFLD (Metabolic Associated Fatty Liver Disease) N/A
Recruiting NCT05855239 - Quantification of Hepatic Steatosis With Different Ultrasound Frequency
Recruiting NCT05877547 - A Clinical Study of Efinopegdutide in Participants With Precirrhotic Nonalcoholic Steatohepatitis (NASH) (MK-6024-013) Phase 2
Completed NCT04462562 - Quantitative US for Evaluation of Hepatic Steatosis in NAFLD N/A
Completed NCT04054297 - Glycemic Index/Saturated Fatty Acid Diet and Hepatic Fat N/A
Not yet recruiting NCT06215131 - Feasibility of Immersive Virtual Reality Dietician Program in Metabolic-dysfunction Associated Steatotic Liver Disease N/A
Completed NCT03593343 - Hepatic Glycogen and Fat Oxidation N/A
Recruiting NCT06257732 - Different Exercise Modalities in the Treatment of NAFLD and Their Impact on Myokines N/A
Completed NCT02983669 - The Effects of Zataria Multiflora Boiss (Shirazi's Thyme) on Nonalcoholic Fatty Liver Disease N/A
Recruiting NCT02764047 - Probiotics in the Treatment of NAFLD N/A